Eric A. Toth

University of Maryland, Baltimore — United States

Medicine · Health Sciences

27h-index1.9kcitations94works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(20), Hepatitis C virus research(18), S100 Proteins and Annexins(13), Enzyme Structure and Function(11), Hepatitis B Virus Studies(9)

Publications94 total

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design
Nature Communications·2026Open Access
Substrate specificity in a designed RAS-targeting protease is coupled to active site and distal motions
2026Open Access
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope
2026Open Access
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cure
2025· 1 citedOpen Access
Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens
Vaccines·2025Open Access
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein‐Protein Interaction Identification in Glycoengineered CHO Cells
Biotechnology Journal·2025· 2 citedOpen Access
Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens
Preprints.org·2025Open Access
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity
npj Vaccines·2025· 5 citedOpen Access
Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers
Communications Biology·2025· 2 citedOpen Access
Enhanced Production of HCV E1E2 Subunit Vaccine Candidates via Protein-Protein Interaction Identification in Glycoengineered CHO cells
2025Open Access
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design
2025· 2 citedOpen Access
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicity
2025Open Access
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist—Synthesis, Characterization, and In Vivo Activity
Journal of Functional Biomaterials·2025· 3 citedOpen Access
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist – Synthesis, Characterization and In Vivo Activity
Preprints.org·2024· 1 citedOpen Access
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Viruses·2024· 12 citedOpen Access
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived protein
2024· 1 citedOpen Access
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Preprints.org·2024· 2 citedOpen Access
Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
New Biotechnology·2023· 3 citedOpen Access
Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine
Reviews in Medical Virology·2023· 10 citedOpen Access
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
Nature Communications·2023· 31 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Thomas R. Fuerst(13), David J. Weber(9), Edwin Pozharski(9), Paul T. Wilder(8), Alexander K. Andrianov(7), Brian G. Pierce(7), Gerald M. Wilson(6), Kristen M. Varney(6), Alexander D. MacKerell(6), Ruixue Wang(6), Alexander Marin(6), Roy A. Mariuzza(6), Dimeka N. Patterson(5), Thomas H. Charpentier(5), Andrew Coop(5), Johnathan D. Guest(5), Jeff D. Ballin(4), Jade Bernstein(4), Melissa A. Liriano(4), L.S. Pidugu(4)